Trials / Completed
CompletedNCT00185068
An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension
A Prospective, Open Label, Titration Study to Assess the Efficacy and Safety of Benicar® and Benicar ®HCT in Patients With Stage II Systolic Hypertension
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 110 (planned)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Effect of increasing doses of olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide on blood pressure in patients with hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olmesartan medoxomil | |
| DRUG | Olmesartan medoxomil/hydrochlorothiazide | |
| DRUG | Hydrochlorothiazide |
Timeline
- Start date
- 2004-03-01
- Completion
- 2004-10-01
- First posted
- 2005-09-16
- Last updated
- 2005-09-16
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00185068. Inclusion in this directory is not an endorsement.